CDK12 overexpression increases the phosphorylation of antiapoptotic proteins, including Survivin and MCL-1 and correlates with shorter overall survival in breast cancer, ovarian cancer and gastric cancer (99, 100). Here, CDK12 is linked to gastric cancer.